Abstract:<p>Epidemiological studies have demonstrated that the general population's exposure to bisphenol A (BPA) substitutes is ubiquitous. Bisphenol F (BPF), one of the main BPA substitutes, is increasingly replacing BPA in plastics for food and beverage applications. Accumulating evidence suggests that BPA exposure is associated with nonalcoholic fatty liver disease (NAFLD)-like changes. However, the potential effects of BPF on lipid homeostasis remain poorly understood. In the present study, an epidemiological analysis with LC-MS-MS revealed that the BPF concentrations in the serum of NAFLD patients were significantly higher than those in a control group. Supporting this result, using Oil Red O, BODIPY 493/503, LipidTox Deep Red staining and gas chromatography-time-of-flight mass spectrometry (TOF-MS) assays, we found that BPF exposure induced NAFLD-like changes, with obvious lipid droplet deposition, triglyceride (TG) and fatty acids increase in mouse livers. Meanwhile, lipid droplet deposition and TG increase induced by BPF were also observed in HepG2 cells, accompanied by autophagic flux blockade, including autophagosome accumulation and the decreased degradation of SQSTM1/p62. Using adenoviruses dual-reporter plasmid RFP-GFP-LC3, RFP-GFP-PLIN2 transfection, AO staining, and EGFR degradation assays, we demonstrated that BPF treatment impaired lysosomal degradative capacity, since BPF treatment obviously impaired lysosomal acidification, manifested as decreased lysosomal hydrolase cathepsin L (CTSL) and mature cathepsin D (CTSD) in HepG2 and mouse liver issues. Additionally, v-ATPase D, a multi-subunit enzyme that mediates acidification of eukaryotic intracellular organelles, significantly decreased after BPF exposure in both the vitro and in vivo studies.</p><p>This study ascertained a novel mechanism involving dysfunctional of lysosomal degradative capacity induced by BPF, which contributes to lipophagic disorders and causes lipid droplet deposition. This work provides evidence that lysosomes may be a target organelle where BPF exerts its potential toxicity; therefore, novel intervention strategies targeting lysosome are promising for BPF-induced NAFLD-like changes.</p>

In Vivo Hypoglycemic Effects of Bisphenol F Exposure in High-Fat Diet Mice.

Long-term Exposure to Low Doses of Bisphenol S Has Hypoglycaemic Effect in Adult Male Mice by Promoting Insulin Sensitivity and Repressing Gluconeogenesis.

Bisphenol F induced hyperglycemia via activation of oxidative stress-responsive miR-200 family in the pancreas

BPA and Its Alternatives BPF and BPAF Exaggerate Hepatic Lipid Metabolism Disorders in Male Mice Fed a High Fat Diet

Bisphenol-S and Bisphenol-F alter mouse pancreatic β-cell ion channel expression and activity and insulin release through an estrogen receptor ERβ mediated pathway

Impairment of Bisphenol F on the Glucose Metabolism of Zebrafish Larvae.

Gestational Exposure to Bisphenol AF Causes Endocrine Disorder of Corpus Luteum by Altering Ovarian SIRT-1/Nrf2/NF-kB Expressions and Macrophage Proangiogenic Function in Mice.

Obesogenic effect of Bisphenol P on mice via altering the metabolic pathways

A lipidomic approach to bisphenol F-induced non-alcoholic fatty liver disease-like changes: altered lipid components in a murine model

High-fat diet aggravates glucose homeostasis disorder caused by chronic exposure to bisphenol A.

Bisphenol Analogues Induced Metabolic Effects Through Eliciting Intestinal Cell Heterogeneous Response.

Effects of perinatal exposure to BPA and its alternatives (BPS, BPF and BPAF) on hepatic lipid and glucose homeostasis in female mice adolescent offspring

Bisphenol F induces liver-gut alteration in zebrafish

Bisphenol AF exposure causes fasting hyperglycemia in zebrafish (Danio rerio) by interfering with glycometabolic networks

The in vivo action of chronic bisphenol F showing potential immune disturbance in juvenile common carp (Cyprinus carpio)

Long-term Bisphenol S exposure induced gut microbiota dysbiosis, obesity, hepatic lipid accumulation, intestinal lesions and dyslipidemia in mice

Bisphenol F induces nonalcoholic fatty liver disease-like changes: Involvement of lysosome disorder in lipid droplet deposition

Bisphenol a Accelerates the Glucolipotoxicity-Induced Dysfunction of Rat Insulinoma Cell Lines: an Implication for a Potential Risk of Environmental Bisphenol a Exposure for Individuals Susceptible to Type 2 Diabetes

Sex- and Dose-Specific Effects of Maternal Bisphenol A Exposure on Pancreatic Islets of First- and Second-Generation Adult Mice Offspring

Hepatic Toxicity of Fluorene-9-bisphenol (BHPF) on CD-1 Mice

Transcriptomics integrated with metabolomics reveals the effect of Bisphenol F (BPF) exposure on intestinal inflammation